Company Profile

Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - sale of products (95.4%): heart pumps (Impella brand); - sale of services (4.6%): including preventive maintenance services. Net sales are distributed geographically as follows: the United States (81.2%), Europe (12.8%), Japan (5%) and other (1%).

Employees

2,003

Sector

Advanced Medical Equipment & Technology

More about the company

28/10/24	Abiomed, Inc. Announces Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI	CI
23/10/23	Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium	CI
23/12/22	ABIOMED, Inc. Announces Termination of Todd A. Trapp as Chief Financial Officer	CI
23/12/22	ABIOMED, Inc. Announces Management Changes	CI
23/12/22	ABIOMED, Inc. Announces Termination of Michael R. Minogue as Chief Executive Officer	CI
23/12/22	Johnson & Johnson Closes Acquisition of Abiomed	MT
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from NASDAQ Composite Index	CI
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index	CI
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global 1200	CI
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Healthcare Equipment Select Industry Index	CI
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment & Services (Industry Group)	CI
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment & Supplies	CI
22/12/22	Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Composite 1500	CI

02/11/22	Morgan Stanley Upgrades Abiomed to Equalweight From Underweight, Boosts Price Target to $380 From $235	MT
02/11/22	Deutsche Bank Downgrades Abiomed to Hold From Buy, Adjusts Price Target to $388 From $355	MT
02/11/22	Analyst recommendations: BAT, Microsoft, NXP Semi, Snowflake, Clorox...
02/11/22	William Blair Downgrades Abiomed to Market Perform From Outperform	MT
02/11/22	Piper Sandler Downgrades Abiomed to Neutral From Overweight, Adjusts Price Target to $380 From $350	MT

08/04/24	Johnson & Johnson to Acquire Shockwave Medical	AQ
23/04/23	ISHLT and ISHLT Foundation Fund Research and Career Development with Grants	AQ
23/12/22	ABIOMED INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
22/12/22	FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial	BU
07/12/22	Abiomed - First Patients in the World Treated with Impella RP Flex with SmartAssist	AQ

23/12/22	J&J : finalise l'acquisition d'Abiomed
22/12/22	La FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivot
22/12/22	Impella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommen
20/12/22	Bolsa de Madrid: Japónimación
20/12/22	En Direct des Marchés : Orange, Engie, Vinci, Elior, Derichebourg, Siemens, Xiaomi, Boeing...

Manager	Title	Age	Since
Jeff Caravella DFI	Director of Finance/CFO	-	01/01/2025
Poornima Sood CTO	Chief Tech/Sci/R&D Officer	-	01/04/2022
Will Danzinger COO	Chief Operating Officer	-	01/01/2023

Abiomed, Inc. Stock

Equities

ABMD

US0036541003

Advanced Medical Equipment & Technology

Latest news: Abiomed, Inc.

Analysts' recommendations: Abiomed, Inc.

Press Releases: Abiomed, Inc.

News in other languages: Abiomed, Inc.

Quotes and Performance

Managers and Directors: Abiomed, Inc.

ETFs: Abiomed, Inc.

Other Advanced Medical Equipment & Technology

Company Profile

Director	Title	Age	Since
David Fortunati BRD	Director/Board Member	-	22/12/2022
Vincent Sommella BRD	Director/Board Member	-	22/12/2022
Susan Morano BRD	Director/Board Member	-	22/12/2022

Name		Varia. Jan 1.	Weight	AuM
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY		-1.55%	0.44%	26 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED		0.00%	0.33%	2 M€

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ABIOMED, INC.	+0.06%	+0.23%	-	-	17.19B
THERMO FISHER SCIENTIFIC, INC.	-1.94%	-1.58%	-5.07%	-8.04%	186B
INTUITIVE SURGICAL, INC.	-1.56%	-2.33%	+0.67%	+116.17%	173B
DANAHER CORPORATION	-1.80%	-4.31%	-4.88%	-18.57%	138B
BOSTON SCIENTIFIC CORPORATION	-2.70%	-5.27%	-25.68%	+50.52%	104B
SIEMENS HEALTHINEERS AG	-1.19%	-4.97%	-23.68%	-19.60%	51.95B
EDWARDS LIFESCIENCES CORPORATION	+1.80%	+0.59%	+25.17%	+15.39%	49.82B
RESMED, INC.	-2.30%	-4.32%	+4.43%	+20.04%	35.84B
GE HEALTHCARE TECHNOLOGIES INC.	-3.83%	-6.91%	-14.80%	-2.99%	33.15B
AGILENT TECHNOLOGIES, INC.	-1.04%	-3.03%	-5.31%	-14.95%	32.62B
Average	-1.04%	-3.04%	-5.46%	+15.33%	89.28B
Weighted average by Cap.	-1.16%	-2.87%	-5.78%	+26.27%